Company Filing History:
Years Active: 2018-2022
Title: Sherif Daouti: Innovator in Bispecific Antibodies
Introduction
Sherif Daouti is a notable inventor based in Totowa, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the development of bispecific antibodies. With a total of 2 patents, his work focuses on innovative solutions for medical applications.
Latest Patents
Sherif Daouti's latest patents include groundbreaking inventions related to antibodies specific for DR5. The first patent describes bispecific antibodies that comprise at least one antigen binding site specific for DR5 and at least one antigen binding site specific for FAP. This invention also covers methods for their production, pharmaceutical compositions containing these antibodies, and their various uses. The second patent similarly focuses on bispecific antibodies specific for FAP and DR5, emphasizing the importance of these antibodies in therapeutic applications.
Career Highlights
Sherif Daouti is currently associated with Roche Glycart AG, where he continues to advance his research in antibody development. His work has the potential to impact cancer treatment and other medical fields significantly.
Collaborations
Some of his notable coworkers include Peter Bruenker and Ningping Feng, who contribute to the innovative environment at Roche Glycart AG.
Conclusion
Sherif Daouti's contributions to the field of bispecific antibodies exemplify the innovative spirit of modern biotechnology. His patents reflect a commitment to advancing medical science and improving patient outcomes.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.